Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.
Nonalcoholic fatty liver disease (NAFLD) has been associated with glucocorticoid excess and androgen deficiency, yet in the majority of patients with steatohepatitis, circulating cortisol and androgen levels are normal. The enzyme 5α-reductase (5αR) has a critical role in androgen and glucocorticoid...
Main Authors: | Dowman, J, Hopkins, L, Reynolds, G, Armstrong, M, Nasiri, M, Nikolaou, N, van Houten, E, Visser, J, Morgan, SA, Lavery, G, Oprescu, A, Hübscher, S, Newsome, P, Tomlinson, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
5-ALPHA-REDUCTASE-1 KNOCKOUT PROTECTS AGAINST HEPATOCARCINOGENESIS IN A MURINE MODEL OF NASH
by: Dowman, J, et al.
Published: (2012) -
Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
by: Dowman, J, et al.
Published: (2014) -
Current therapeutic strategies in non-alcoholic fatty liver disease.
by: Dowman, J, et al.
Published: (2011) -
Dual-5α-reductase inhibition promotes hepatic lipid accumulation in man.
by: Hazlehurst, J, et al.
Published: (2016) -
Pathogenesis of non-alcoholic fatty liver disease.
by: Dowman, J, et al.
Published: (2010)